Late-onset Alzheimer’s disease is associated with senescent and cell-cycle-reengaging neurons in a human brain study; a multi-ancestry cohort links APOE and polygenic scores with higher risk. Observational studies associate high cholesterol with disease, whereas a Mendelian randomization study links genetically predicted cholesterol with lower risk.
60 findings in 35 papers from 2018 to 2026, 5 of them since June 2026
“Inverse-variance weighting associated genetically predicted insomnia with higher odds of late-onset AD (OR = 3.36, 95% CI 1.02–10.99; P = 0.045).”
Low plasma Klotho was not clearly linked with late-onset Alzheimer's disease in humans (comparison of vascular dementia with late-onset Alzheimer's disease).
Humanscomparison of vascular dementia with late-onset Alzheimer's disease
Insomnia is associated with late-onset Alzheimer's disease in humans (Genetically predicted insomnia; two-sample Mendelian randomization) (OR 3.36, 95% CI 1.02–10.99; P = 0.045).
Human cohorts link late-onset Alzheimer's disease with APOE-related genetic risk, and a study of human brains links it with senescent neurons. Cholesterol results differ: observational studies associate high cholesterol with the disease, while a Mendelian randomization study links genetically predicted cholesterol with lower risk.
In two observational cohorts, genetic scores were linked to faster progression to Alzheimer’s disease, with hazard ratios, a measure of risk over time, of 1.25 to 2.02.In two observational cohorts, genetic scores were linked to faster progression to Alzheimer’s disease, with hazard ratios, a measure of risk over time, of 1.25 to 2.02.
A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.